CALCIUM TRANSPORT PATHWAY (PW:0001139)
Description
Calcium permeates almost every aspect of cellular processes and the pathways associated with them - from proliferation to cell death, contraction and gene expression, hormone and neurotransmitter release, metabolism and synaptic plasticity. Movement of calcium ions in and outside of the cell is paramount to the maintenance of a calcium gradient four order of magnitudes between the extracellular environment and the cytoplasmic concentration of resting cells. The steep gradient allows for fast local increases in cytoplasmic concentration that underlie the broad range of cellular functions mediated by calcium signaling. A large array of channels at the plasma membrane or the endoplasmic/sarcoplasmic reticulum (ER/SR) mediates calcium entry or release into the cytoplasm; all activated by a variety of stimuli and ligands and in the case of ER/SR channels by calcium itself, also referred to as calcium initiated calcium release (CICR). Extending this initial input, characterized as 'puff', 'blip', 'spark' or 'wave' depending on its spatiotemporal features, a broad spectrum of calcium sensors further carry out the calcium signaling tasks. The increase in calcium ion concentration is transient to prevent its possible toxic effect; in high amount, Ca2+ can aggregate nucleic acids and proteins or impact on the integrity of lipid membranes. Extrusion of calcium ions outside the cell or back into ER/SR is carried out by ATP dependent pumps and exchangers, effectively regulating the calcium signal. Calcium buffers also help maintain the relatively low, ~100nM free calcium concentration of the resting cell. Channels, pumps and exchangers mediating the movement of calcium in and out of cells and organelles control the balance between the provision of the signal and its timely removal; they are shown in the generic diagram and briefly described. As integral components of the 'calcium signaling kit', they are also present in the calcium/calcium-mediated signaling interactive pathway diagram -
click here to access it directly ,
(or on the diagram to get to its ontology report).
Prominent players are the voltage operated or voltage-gated, calcium channels (VOCs); they are activated by changes in membrane potential and the flow of calcium initiates signaling events controlling many cellular processes in both excitable and non-excitable cells. In cardiac and muscle cells, calcium entry mediates contraction and also prompts CICR from intracellular stores; in neurons and endocrine cells, it initiates synaptic transmission and hormone release, respectively. Structurally, they are multi-subunit complexes of which alpha is the pore forming subunit and the beta, gamma or delta are ancillary. The alpha subunits differ by the type of Ca2+ currents and can be subdivided into three subfamilies of which the L-type channels are better characterized. The alpha subunit is subject to processing and post-translational modifications that modulate its function. Modulators include Ca2+ sensors and effectors such as calmodulin (CaM), the rather universal Ca2+ sensor.
Transient receptor potential channels (TRPs), when activated depolarize the membrane leading to flow of Na+ and Ca2+ ions into the cell. Overall, the TRP channels are weakly voltage sensitive and mostly nonselective ion channels. The rather large family is subdivided into several subfamilies; Ca2+ selectivity appears to be confined to a subgroup of the 'vanilloid' TRPV family. A member of the mucolipin family, Mcoln1 known as TRPML1, is a Ca2+ and Fe2+ release channel located in lysosomes and late endosomes. Cyclic nucleotide gated channels (CNGs) respond to changes in the intracellular concentration of cGMP and also cAMP to increase Ca2+ concentration in photoreceptor and olfactory cells. Store operated (ORAIs) channels represent a special class as they are not activated by extracellular stimuli but by reduction of calcium in ER with the Stim proteins playing a central role. In the resting state, the EF-hand containing calcium sensor proteins are located in the ER; upon Ca2+ depletion and dissociation of the ion from the EF-hand domain, the proteins oligomerize, translocate to ER-plasma membrane junctions where they couple to and activate the channels. Finally, transmitter/small molecule (acetylcholine, glutamate, ATP) gated ion channels (eg AMPA, NMDA, purinergic) or receptor operated channels (ROCs) are permeable to Ca2+ and other ions and function in neuron-to-neuron signaling, learning, memory and synaptic plasticity, among others; their detailed description is beyond the scope of this synopsis. The link provides a brief description and selected references; they will be individually presented in the context of neurotransmitters/small molecule signaling pathways with which they are associated.
Signaling via G-protein coupled (GPCR) or tyrosine kinase (TKR) receptors leads to generation of inositol 1,4,5,-trisphosphate (IP3) and diacylglycerol (DAG) second messengers. IP3 binds IP3 receptors (ITPRs) in ER to prompt, along with Ca2+ , the release of the ion from ER stores. The functional receptor is a tetramer and in higher organisms, diversity is achieved by the presence of three genes, their splice variants and the possible formation of both homo- and heterotetramers. Phosphorylation and dephosphorylation events and interaction with other partners, in turn subject to phosphorylation/dephosphorylation regulation, modulate their activity. Ahcyl1, known as IRBIT, and the anti-apoptotic Bcl2 are important partners; phosphorylated Ahcyl1 binds to the receptor to a site overlapping the IP3 site and inhibits the receptor by competing with IP3 binding. IRBIT has roles beyond ITPR regulation, such as the control of epithelial fluid and bicarbonate secretion. In a similar fashion Ca2+ and cyclic ADP ribose (cADPr) activate the ryanodine receptors (RYRs) to prompt Ca2+ release from SR stores during excitation-contraction coupling in both cardiac and skeletal muscle. Of note is that in skeletal muscle Ryr1 is in physical contact with the Cacna1s (Cav1.1) channel leading to 'voltage-induced' Ca2+ release; in cardiac muscle, Ryr2 mediated Ca2+ release is initiated in response to Ca2+ influx via Cacna1c(Cav1.2), or CICR. The receptors, which are represented by three genes, are homotetramers and are found in protein complexes with several partners that exert various effects; they include Ca2+ buffers such as calsequestrins or stabilizing proteins such as calstabins, among others. The Ca2+ sensor CaM acts as a partial agonist in its apo- (Ca2+ free) form whereas the Ca2+-bound CaM acts as an inhibitor. Mutations in RYR1 and 2 are associated with a number of human diseases. Both the ITPRs and RYRs are large molecules with RYRs being the largest; both possess Ca2+ binding sites that differ in their affinity for and which mediate the stimulatory or inhibitory effect of the metal ion.
Pumps are P-type ATPases that use the energy of ATP to transport Ca2+ outside the cell or back into the ER/SR against its concentration gradient. They exchange protons for two or one Ca2+ pumped into ER/SR or outside the cell, per ATP hydrolyzed, respectively; there are two Ca2+ binding sites in SERCA pumps whereas the plasma membrane PMCA pumps have one. There are three ER/SR (SERCAs, ATP2A1-3) and four plasma membrane (PMCAs, ATP2B1-4) pumps. Other pumps are represented by the Golgi ATPases (SPCA, ATP2C1 and 2) which also transport Mn2+, a feature that probably relates to the Mn2+ requiring enzymes in the lumen of Golgi, such as the glycosyltransferases.
Another mechanism for Ca2+ extrusion outside the cell involves exchangers: the Na+/Ca2+ exchangers (NCX or SLC8A1-3) and the Na+/Ca2+ -K+ exchangers (NCKX or SLC24A1-5) exchange one Ca2+ for three Na+ ions or co-transport one Ca2+ and one K+ in exchange for four Na+, respectively.
In the mitochondria, the uptake of Ca2+ is favored by the electrochemical proton gradient the electron transport chain pathway generates and is mediated by the Mcu mitochondrial uniporter complex - a selective channel that moves the ion across the mitochondrial inner membrane. In the opposite direction, a Na+/Li+/ Ca2+ exchanger (Slc24a6) promotes release of the metal ion. Nicotinic acid adenine dinucleotide phosphate (NAADP)-gated calcium channels, the two-pore segment channels represented by the two members in humans (TPCN1 and 2) and rodents in the family of three in most other mammals, mediate Ca2+ release from acidic stores in endosomic/lysosomic compartments. Whether TPCNs and perhaps ryanodine channels directly bind NAADP or binding is mediated by some other intermediary protein, is not yet a fully settled issue. The identity of the uptake mechanism in the acidic stores has not been elucidated; a putative Ca2+/H+ exchanger has been postulated. Of note is the fact that in mammalian cells, a multifunctional ATP ribosyl cyclase can generate NAADP or cADPr depending on whether the cofactor used is NADP or NAD, respectively.
Channels activated by/responding to increase in intracellular Ca2+ such as members of the potassium or chloride channels are not part of this balanced gradient control and are not shown; likewise not shown are buffers which do play a role but are not involved in calcium transport/movement. These molecules are responders and modulators of calcium signaling, respectively and along with sensors and other players will be presented in the context of calcium/calcium-mediated signaling.
The movement of calcium ion in and out of cells and organelles, the regulated availability of the free metal ion and the interaction with its many sensors, the calcium transport and calcium-mediated signaling pathways are inextricably connected. Together, they are the components of the 'calcium signaling kit' and together, they orchestrate the homeostasis of what is probably the most versatile element in the kingdoms of life. To see the ontology report for annotations, Gviewer and download, click here ...(less)
Pathway Diagram:
Genes in Pathway:
G
Atp2a1
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:190,457,198...190,475,423
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934
G
Atp2a3
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr10:58,079,710...58,111,279
Ensembl chr10:58,079,852...58,111,278
G
Atp2b1
ATPase plasma membrane Ca2+ transporting 1
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:35,622,461...35,731,904
G
Atp2b2
ATPase plasma membrane Ca2+ transporting 2
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr 4:148,450,207...148,763,653
Ensembl chr 4:148,450,207...148,696,239
G
Atp2b3
ATPase plasma membrane Ca2+ transporting 3
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr X:156,367,582...156,464,085
Ensembl chr X:156,367,852...156,438,153
G
Atp2b4
ATPase plasma membrane Ca2+ transporting 4
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr13:47,708,157...47,807,389
Ensembl chr13:47,711,121...47,758,876
G
Atp2c1
ATPase secretory pathway Ca2+ transporting 1
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr 8:114,913,551...115,034,706
Ensembl chr 8:114,913,415...115,038,826
G
Atp2c2
ATPase secretory pathway Ca2+ transporting 2
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr19:64,662,729...64,719,998
Ensembl chr19:64,662,715...64,719,996
G
Cacna1a
calcium voltage-gated channel subunit alpha1 A
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr19:40,425,560...40,724,810
Ensembl chr19:40,425,560...40,724,599
G
Cacna1b
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr 3:27,779,133...27,944,292
Ensembl chr 3:27,779,166...27,944,285
G
Cacna1c
calcium voltage-gated channel subunit alpha1 C
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,233,690...5,674,692
G
Cacna1e
calcium voltage-gated channel subunit alpha1 E
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr13:69,125,048...69,613,795
Ensembl chr13:69,132,305...69,612,983
G
Cacna1f
calcium voltage-gated channel subunit alpha1 F
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr X:17,539,992...17,568,308
Ensembl chr X:17,539,920...17,568,308
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,851,896...79,919,634
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr10:14,894,630...14,952,317
Ensembl chr10:14,894,641...14,952,771
G
Cacna1i
calcium voltage-gated channel subunit alpha1 I
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr 7:113,716,266...113,827,670
Ensembl chr 7:113,716,266...113,827,670
G
Cacna1s
calcium voltage-gated channel subunit alpha1 S
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr13:50,045,668...50,115,903
Ensembl chr13:50,045,668...50,115,903
G
Cacnb1
calcium voltage-gated channel auxiliary subunit beta 1
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr10:83,494,509...83,515,164
Ensembl chr10:83,494,509...83,515,146
G
Cacnb2
calcium voltage-gated channel auxiliary subunit beta 2
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr17:82,473,097...82,818,564
Ensembl chr17:82,473,129...82,818,564
G
Cacnb3
calcium voltage-gated channel auxiliary subunit beta 3
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr 7:131,663,810...131,676,085
Ensembl chr 7:131,662,545...131,676,085
G
Cacnb4
calcium voltage-gated channel auxiliary subunit beta 4
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr 3:57,315,900...57,578,271
Ensembl chr 3:57,315,900...57,578,220
G
Cnga1
cyclic nucleotide gated channel subunit alpha 1
TAS
RGD
PMID:12087135
RGD:6893549
NCBI chr14:35,920,948...35,959,065
Ensembl chr14:35,926,854...35,959,056
G
Cnga2
cyclic nucleotide gated channel subunit alpha 2
TAS
RGD
PMID:12087135
RGD:6893549
NCBI chr X:154,741,742...154,759,814
Ensembl chr X:154,741,764...154,759,814
G
Cnga3
cyclic nucleotide gated channel subunit alpha 3
TAS
RGD
PMID:12087135
RGD:6893549
NCBI chr 9:46,943,353...46,989,862
Ensembl chr 9:46,928,810...46,989,862
G
Cnga4
cyclic nucleotide gated channel subunit alpha 4
TAS
RGD
PMID:12087135
RGD:6893549
NCBI chr 1:169,134,332...169,168,317
Ensembl chr 1:169,164,206...169,168,224
G
Cngb1
cyclic nucleotide gated channel subunit beta 1
TAS
RGD
PMID:12087135
RGD:6893549
NCBI chr19:9,732,646...9,798,864
Ensembl chr19:9,732,646...9,797,224
G
Cngb3
cyclic nucleotide gated channel subunit beta 3
ISO
RGD
PMID:12087135
RGD:6893549
NCBI chr 5:37,543,903...37,792,030
Ensembl chr 5:37,543,903...37,792,030
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
ISO
RGD
PMID:19133301
RGD:7204693
NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504
G
Itpr2
inositol 1,4,5-trisphosphate receptor, type 2
ISO
RGD
PMID:19133301
RGD:7204693
NCBI chr 4:180,759,325...181,165,361
Ensembl chr 4:180,760,442...181,164,763
G
Itpr3
inositol 1,4,5-trisphosphate receptor, type 3
ISO
RGD
PMID:19133301
RGD:7204693
NCBI chr20:5,138,553...5,204,189
Ensembl chr20:5,118,834...5,204,184
G
Mcoln1
mucolipin TRP cation channel 1
ISO
RGD
PMID:20716668
RGD:7204689
NCBI chr12:6,357,851...6,372,151
Ensembl chr12:6,357,807...6,372,151
G
Mcu
mitochondrial calcium uniporter
ISO
RGD
PMID:22850819
RGD:7204696
NCBI chr20:27,960,520...28,123,103
Ensembl chr20:27,961,327...28,123,103
G
Orai1
ORAI calcium release-activated calcium modulator 1
ISO
RGD
PMID:22914293
RGD:7204692
NCBI chr12:39,195,139...39,209,030
Ensembl chr12:39,195,163...39,209,408
G
Orai2
ORAI calcium release-activated calcium modulator 2
ISO
RGD
PMID:22914293
RGD:7204692
NCBI chr12:26,136,922...26,157,041
Ensembl chr12:26,132,193...26,157,041
G
Orai3
ORAI calcium release-activated calcium modulator 3
ISO
RGD
PMID:22914293
RGD:7204692
NCBI chr 1:191,811,671...191,816,530
Ensembl chr 1:191,811,424...191,816,530
G
Ryr1
ryanodine receptor 1
ISO
RGD
PMID:20961976
RGD:7204694
NCBI chr 1:93,420,078...93,551,305
Ensembl chr 1:93,420,078...93,551,305
G
Ryr2
ryanodine receptor 2
ISO
RGD
PMID:20961976
RGD:7204694
NCBI chr17:63,081,527...63,667,141
Ensembl chr17:63,081,527...63,666,705
G
Ryr3
ryanodine receptor 3
ISO
RGD
PMID:20961976
RGD:7204694
NCBI chr 3:119,886,129...120,433,465
Ensembl chr 3:119,885,878...120,433,677
G
Slc24a1
solute carrier family 24 member 1
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 8:74,334,556...74,361,313
Ensembl chr 8:74,335,053...74,361,268
G
Slc24a2
solute carrier family 24 member 2
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 5:106,543,867...106,787,810
Ensembl chr 5:106,543,874...106,787,780
G
Slc24a3
solute carrier family 24 member 3
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 3:153,005,418...153,504,497
Ensembl chr 3:153,004,987...153,504,497
G
Slc24a4
solute carrier family 24 member 4
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 6:127,044,470...127,184,684
Ensembl chr 6:127,044,470...127,184,684
G
Slc24a5
solute carrier family 24 member 5
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 3:132,772,804...132,792,342
Ensembl chr 3:132,772,804...132,792,342
G
Slc8a1
solute carrier family 8 member A1
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:18,946,798...19,287,964
G
Slc8a2
solute carrier family 8 member A2
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 1:85,944,752...85,982,900
Ensembl chr 1:85,947,204...85,981,889
G
Slc8a3
solute carrier family 8 member A3
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 6:106,605,611...106,739,208
Ensembl chr 6:106,605,621...106,721,412
G
Slc8b1
solute carrier family 8 member B1
ISO
RGD
PMID:22850819
RGD:7204696
NCBI chr12:41,690,333...41,713,657
Ensembl chr12:41,690,334...41,713,601
G
Stim1
stromal interaction molecule 1
ISO
RGD
PMID:22914293
RGD:7204692
NCBI chr 1:166,067,450...166,230,733
Ensembl chr 1:166,067,962...166,233,108
G
Stim2
stromal interaction molecule 2
ISO
RGD
PMID:22914293
RGD:7204692
NCBI chr14:61,091,550...61,217,281
Ensembl chr14:61,091,550...61,217,080
G
Tpcn1
two pore segment channel 1
ISO
RGD
PMID:20018950
RGD:7204697
NCBI chr12:41,633,399...41,690,200
Ensembl chr12:41,633,398...41,690,200
G
Tpcn2
two pore segment channel 2
ISO
RGD
PMID:20018950
RGD:7204697
NCBI chr 1:209,845,827...209,875,561
Ensembl chr 1:209,845,835...209,875,457
G
Trpv5
transient receptor potential cation channel, subfamily V, member 5
ISO
RGD
PMID:20716668
RGD:7204689
NCBI chr 4:71,503,085...71,531,134
Ensembl chr 4:71,503,093...71,529,384
G
Trpv6
transient receptor potential cation channel, subfamily V, member 6
ISO
RGD
PMID:20716668
RGD:7204689
NCBI chr 4:71,474,006...71,489,667
Ensembl chr 4:71,474,007...71,489,671
Pathway Gene Annotations
Disease Annotations Associated with Genes in the calcium transport pathway
Atp2a1 Alcohol Myopathy , Brody myopathy , Cachexia , congestive heart failure , Experimental Diabetes Mellitus , genetic disease , Myocardial Reperfusion Injury , Sepsis , Spinal Cord Injuries , type 2 diabetes mellitus Atp2a2 abdominal obesity-metabolic syndrome 1 , acrokeratosis verruciformis , Acute Experimental Pancreatitis , Cachexia , Cardiomegaly , congestive heart failure , Darier Disease, Acral Hemorrhagic Type , Darier Disease, Segmental , Diabetic Cardiomyopathies , essential hypertension , euthyroid sick syndrome , Experimental Diabetes Mellitus , genetic disease , heart disease , hypothyroidism , Iron Overload , keratosis follicularis , left ventricular failure , Myocardial Reperfusion Injury , myocardial stunning , Neointima , pulmonary hypertension , Rhabdomyolysis 2 , Spinal Cord Injuries , status epilepticus , type 2 diabetes mellitus , Ventricular Tachycardia Atp2a3 adenoma , Experimental Diabetes Mellitus , hypertension , type 2 diabetes mellitus Atp2b1 autistic disorder , autosomal dominant intellectual developmental disorder 30 , autosomal dominant intellectual developmental disorder 66 , cataract , clubfoot , coronary artery disease , genetic disease , gestational diabetes , heroin dependence , hypertension , Neurodevelopmental Disorders , pre-eclampsia Atp2b2 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome , agenesis of the corpus callosum with peripheral neuropathy , autosomal dominant nonsyndromic deafness , autosomal dominant nonsyndromic deafness 82 , autosomal recessive nonsyndromic deafness 12 , brain infarction , generalized epilepsy , gestational diabetes , Hearing Loss , Neurodevelopmental Disorders , pre-eclampsia Atp2b3 adenoma , adrenal cortical adenoma , Developmental Disabilities , fetal akinesia deformation sequence syndrome 1 , genetic disease , gestational diabetes , hypertension , Muscle Hypotonia , Neurodevelopmental Disorders , pre-eclampsia , primary hyperaldosteronism , spastic ataxia , Tremor , X-linked spinocerebellar ataxia 1 Atp2b4 dystonia , gestational diabetes , pre-eclampsia , prostate cancer Atp2c1 genetic disease , Hailey-Hailey disease Cacna1a Alternating Hemiplegia of Childhood 1 , amyotrophic lateral sclerosis , Ataxia , Auditory Neuropathy , autism spectrum disorder , cerebellar ataxia , cerebral palsy , childhood absence epilepsy , childhood electroclinical syndrome , developmental and epileptic encephalopathy 1 , developmental and epileptic encephalopathy 2 , developmental and epileptic encephalopathy 42 , developmental and epileptic encephalopathy 52 , Developmental Disabilities , disorder of sexual development , Dysarthria , epilepsy , episodic ataxia , episodic ataxia type 2 , exfoliation syndrome , familial hemiplegic migraine , familial hemiplegic migraine 1 , generalized dystonia , generalized epilepsy , genetic disease , intellectual disability , Lambert-Eaton myasthenic syndrome , migraine , migraine with aura , myoclonic-atonic epilepsy , Nervous System Malformations , neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures , Neurodevelopmental Disorders , progressive bulbar palsy , spastic ataxia , Spastic Paraparesis , spinocerebellar ataxia 6 , Spinocerebellar Ataxias , Sporadic Hemiplegic Migraine , subependymal giant cell astrocytoma , sudden infant death syndrome , temporal lobe epilepsy , Tremor , vascular dementia Cacna1b brain edema , Diabetic Nephropathies , dystonia 23 , Experimental Autoimmune Encephalomyelitis , Hyperalgesia , Lambert-Eaton myasthenic syndrome , multiple sclerosis , Neurodevelopmental Disorder with Seizures and Nonepileptic Hyperkinetic Movements , Neurodevelopmental Disorders , peripheral nervous system disease Cacna1c acute stress disorder , alcohol dependence , Alzheimer's disease , amyloidosis , anxiety disorder , autism spectrum disorder , autistic disorder , bipolar disorder , Brugada syndrome , Brugada syndrome 3 , Cardiac Arrhythmias , cardiomyopathy , cerebral palsy , Cognitive Dysfunction , Congenital Limb Deformities , congestive heart failure , dilated cardiomyopathy , epilepsy , Fetal Growth Retardation , genetic disease , Genetic Predisposition to Disease , Heart Block , hypertension , hypertrophic cardiomyopathy , hypertrophic cardiomyopathy 1 , hypoglycemia , intellectual disability , Joint Instability , Language Development Disorders , long QT syndrome , long QT syndrome 1 , long QT syndrome 8 , major depressive disorder , neurodevelopmental disorder with dysmorphic facies and distal limb anomalies , neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures , Neurodevelopmental Disorders , post-traumatic stress disorder , primary immunodeficiency disease , Psychomotor Agitation , Romano-Ward Syndrome , short QT syndrome , Sudden Cardiac Death , Sudden Death , Sudden Unexpected Nocturnal Death Syndrome , tetralogy of Fallot , Timothy syndrome , Tremor , Ventricular Fibrillation, Paroxysmal Familial, 1 , Ventricular Tachycardia , Wolff-Parkinson-White syndrome Cacna1d adenoma , Alcohol Withdrawal Seizures , Animal Disease Models , autism spectrum disorder , autosomal recessive Alport syndrome , bipolar disorder , Bradycardia , colon adenocarcinoma , colon adenoma , congenital disorder of glycosylation Iw , Deafness , Drug-Induced Dyskinesia , epilepsy , Fetal Growth Retardation , genetic disease , Hearing Loss , Heart Block , intellectual disability , long QT syndrome , Memory Disorders , Meniere's disease , Presbycusis , Primary Aldosteronism, Seizures, and Neurologic Abnormalities , primary hyperaldosteronism , prostate cancer , sciatic neuropathy , sick sinus syndrome , Sinoatrial Node Dysfunction and Deafness , Supraventricular Tachycardia , type 2 diabetes mellitus Cacna1e Coma , developmental and epileptic encephalopathy , developmental and epileptic encephalopathy 69 , genetic disease , hyperglycemia , intellectual disability , Van der Woude Syndrome 1 , Wolff-Parkinson-White syndrome Cacna1f Aland Island eye disease , cone-rod dystrophy , congenital stationary night blindness , congenital stationary night blindness 2A , Eye Abnormalities , fundus dystrophy , genetic disease , macular degeneration , myopia , optic atrophy , retinitis pigmentosa , retinitis pigmentosa 1 , X-linked cone-rod dystrophy 3 Cacna1g brain disease , cerebellar ataxia , cerebellar ataxia type 42 , Developmental Disease , genetic disease , hereditary breast ovarian cancer syndrome , intellectual disability , juvenile myoclonic epilepsy , Left Ventricular Hypertrophy , nephrotoxicity , Neurodevelopmental Disorders , spastic ataxia , Spinocerebellar Ataxia 42, Early-Onset, Severe, with Neurodevelopmental Deficits , Spinocerebellar Ataxias Cacna1h arteriovenous malformations of the brain , autistic disorder , beta thalassemia , breast ductal carcinoma , childhood absence epilepsy , Childhood Absence Epilepsy 6 , Drug-Related Side Effects and Adverse Reactions , Familial Hyperaldosteronism, Type IV , focal epilepsy , generalized epilepsy , genetic disease , Hyperalgesia , Idiopathic Generalized Epilepsy , invasive ductal carcinoma , peripheral nervous system disease , primary hyperaldosteronism , sciatic neuropathy Cacna1i Developmental Disabilities , hydrocephalus , Hyperalgesia , long QT syndrome , Neurodevelopmental Disorder with Speech Impairment and with or without Seizures , schizophrenia , sciatic neuropathy , Ventriculomegaly , withdrawal disorder Cacna1s cataract , centronuclear myopathy , congenital myopathy , congenital myopathy 18 , genetic disease , hereditary neuropathy with liability to pressure palsies , hypokalemic periodic paralysis , Hypokalemic Periodic Paralysis, Type 1 , long QT syndrome , Malignant Fever , malignant hyperthermia , muscular atrophy , nephrotoxicity , respiratory failure , Rhabdomyolysis , Sepsis , Thyrotoxic Periodic Paralysis Cacnb2 arrhythmogenic right ventricular cardiomyopathy , autism spectrum disorder , Brugada syndrome , Brugada syndrome 4 , cardiac arrest , Cardiac Arrhythmias , cardiomyopathy , dilated cardiomyopathy , heart conduction disease , hypertension , hypertrophic cardiomyopathy , long QT syndrome , Nerve Injuries , Paroxysmal Ventricular Fibrillation , short QT syndrome , Sudden Death , Sudden Unexpected Nocturnal Death Syndrome , Supraventricular Tachycardia , Ventricular Fibrillation , Ventricular Tachycardia Cacnb3 Nerve Injuries , ovarian cyst Cacnb4 Ataxia , dilated cardiomyopathy , epilepsy , episodic ataxia , episodic ataxia type 5 , generalized epilepsy , Idiopathic Generalized Epilepsy , Idiopathic Generalized Epilepsy 9 , juvenile myoclonic epilepsy , spastic ataxia Cnga1 retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 49 Cnga3 achromatopsia , Achromatopsia 1 , achromatopsia 2 , achromatopsia 3 , color blindness , cone dystrophy , cone-rod dystrophy , Eye Abnormalities , fundus dystrophy , genetic disease , macular degeneration , optic atrophy , retinitis pigmentosa 1 Cngb1 fundus dystrophy , genetic disease , optic atrophy , retinitis pigmentosa , retinitis pigmentosa 1 , retinitis pigmentosa 45 , retinitis pigmentosa 49 Cngb3 achromatopsia , Achromatopsia 1 , achromatopsia 3 , color blindness , cone-rod dystrophy , Eye Abnormalities , fundus dystrophy , genetic disease , Leber congenital amaurosis , macular degeneration , optic atrophy , pathologic nystagmus , retinitis pigmentosa , retinitis pigmentosa 1 , Stargardt disease , Stargardt Disease 1 Itpr1 Alzheimer's disease , anterior segment dysgenesis , asthma , Ataxia , autosomal dominant cerebellar ataxia , Brain Hypoxia , cardiac arrest , cerebellar ataxia , Chemical and Drug Induced Liver Injury , Congenital Mydriasis , diabetes mellitus , dilated cardiomyopathy , epilepsy , genetic disease , gestational diabetes , Gillespie syndrome , Huntington's disease , Hyperalgesia , Hypoxia , intellectual disability , movement disease , multiple sclerosis , nephrotoxicity , neurodegenerative disease , Neurodevelopmental Disorders , Niemann-Pick disease type A , pre-eclampsia , Prostatic Neoplasms , spastic ataxia , spinocerebellar ataxia 15 , spinocerebellar ataxia 29 , Spinocerebellar Ataxias , transient cerebral ischemia Itpr2 amyotrophic lateral sclerosis , Brain Hypoxia , Cardiomegaly , gestational diabetes , intellectual disability , isolated anhidrosis with normal sweat glands , pre-eclampsia Itpr3 acrodermatitis , Animal Disease Models , autism spectrum disorder , autistic disorder , Charcot-Marie-Tooth Disease Type 1J , gestational diabetes , immunodeficiency 133 , long QT syndrome , pre-eclampsia , type 1 diabetes mellitus Mcoln1 acute kidney failure , Corneal Opacity , fundus dystrophy , genetic disease , glycoproteinosis , Growth Disorders , hereditary spastic paraplegia , hereditary spastic paraplegia 5A , intellectual disability , Lisch epithelial corneal dystrophy , mucolipidosis , mucolipidosis type IV , Nervous System Malformations , periventricular leukomalacia Orai1 congenital structural myopathy , genetic disease , hypertension , immunodeficiency 9 , Neoplasm Metastasis , Stormorken syndrome , Tubular Aggregate Myopathies , tubular aggregate myopathy 1 , tubular aggregate myopathy 2 Ryr1 anterior segment dysgenesis , anterior segment dysgenesis 7 , arthrogryposis multiplex congenita , autosomal dominant centronuclear myopathy , autosomal dominant intellectual developmental disorder 26 , Axial Myopathy, Late-Onset , cardiomyopathy , caudal regression syndrome , centronuclear myopathy , centronuclear myopathy 1 , clubfoot , Congenital Hip Dislocation , congenital muscular dystrophy , congenital myasthenic syndrome , congenital myasthenic syndrome 12 , congenital myopathy , congenital myopathy 1A , congenital myopathy 1B , congenital myopathy 4A , Congenital Neuromuscular Disease, with Uniform Type 1 Fiber , congenital structural myopathy , congestive heart failure , distal arthrogryposis , Dwarfism , fetal akinesia deformation sequence syndrome 1 , genetic disease , gestational diabetes , GNE myopathy , Heat Stroke , hereditary nonpolyposis colorectal cancer type 5 , Hydrops Fetalis , intracranial vasospasm , isolated elevated serum creatine phosphokinase levels , King Denborough syndrome , Lead Poisoning , Left Ventricular Hypertrophy , long QT syndrome , Malignant Fever , malignant hyperthermia , Malignant Hypothermia , Mitochondrial Progressive Myopathy with Congenital Cataract, Hearing Loss, and Developmental Delay , Muscle Hypotonia , muscle tissue disease , Myalgia , myocardial infarction , myopathy , Myotonia , nephrotoxicity , neuromuscular disease , osteochondrodysplasia , osteogenesis imperfecta type 1 , osteoporosis , pre-eclampsia , primary pulmonary hypertension , ptosis , pulmonary hypertension , renal cell carcinoma , respiratory failure , Rhabdomyolysis , rigid spine muscular dystrophy 1 , scoliosis , Sepsis , Spinal Cord Injuries , tubular aggregate myopathy 1 , Uncombable Hair Syndrome 1 Ryr2 arrhythmogenic right ventricular cardiomyopathy , arrhythmogenic right ventricular dysplasia 1 , arrhythmogenic right ventricular dysplasia 9 , autism spectrum disorder , Brugada syndrome , cardiac arrest , Cardiac Arrhythmias , Cardiac Conduction Defect , cardiomyopathy , catecholaminergic polymorphic ventricular tachycardia , catecholaminergic polymorphic ventricular tachycardia 1 , catecholaminergic polymorphic ventricular tachycardia 2 , Childhood Schizophrenia , congenital heart disease , congestive heart failure , coronary artery disease , Diabetic Cardiomyopathies , Diastolic Dysfunction , dilated cardiomyopathy , dilated cardiomyopathy 1B , dilated cardiomyopathy 1C , Dilated Cardiomyopathy with Left Ventricular Noncompaction , Experimental Diabetes Mellitus , familial hypertrophic cardiomyopathy , Familial Sudden Death , Familial Ventricular Tachycardia , gestational diabetes , Heart Block , heart disease , hypertrophic cardiomyopathy , hypertrophic cardiomyopathy 1 , hypertrophic cardiomyopathy 4 , Infant Death , left ventricular noncompaction , long QT syndrome , long QT syndrome 1 , malignant mesothelioma , microcephalic osteodysplastic primordial dwarfism type I , Microcephalic Osteodysplastic Primordial Dwarfism, Type III , Myocardial Ischemia , Paroxysmal Ventricular Fibrillation , pre-eclampsia , pulmonary hypertension , Sudden Cardiac Death , Sudden Death , Syncope , Tachycardia , Ventricular Fibrillation , Ventricular Fibrillation, Paroxysmal Familial, 1 , Ventricular Tachycardia , Wolff-Parkinson-White syndrome Ryr3 colorectal cancer , congenital myopathy 20 , Contracture , developmental and epileptic encephalopathy , generalized epilepsy , genetic disease , gestational diabetes , hepatocellular carcinoma , Hydrops Fetalis , Monomelic Amyotrophy , pre-eclampsia , primary ovarian insufficiency , pulmonary hypertension Slc24a1 Cerebral Hemorrhage , congenital stationary night blindness , congenital stationary night blindness 1D , congenital stationary night blindness autosomal dominant 2 , fundus dystrophy , genetic disease , retinitis pigmentosa , retinitis pigmentosa 1 Slc24a3 adenoid cystic carcinoma , Salivary Gland Neoplasms Slc24a4 amelogenesis imperfecta , amelogenesis imperfecta hypomaturation type 2A5 , genetic disease , Skin/Hair/Eye Pigmentation, Variation In, 6 Slc24a5 genetic disease , ocular albinism 1 , oculocutaneous albinism type VI , Skin/Hair/Eye Pigmentation, Variation In, 4 Slc8a1 Alzheimer's disease , brain ischemia , Cardiomegaly , congestive heart failure , Diabetic Cardiomyopathies , dilated cardiomyopathy , Experimental Diabetes Mellitus , hypertension , megacolon , Myocardial Ischemia , Myocardial Reperfusion Injury , pulmonary hypertension , Reperfusion Injury , status epilepticus Slc8a2 Alzheimer's disease , brain ischemia , Reperfusion Injury , status epilepticus Slc8a3 Alzheimer's disease , brain ischemia , prostate cancer , Reperfusion Injury , status epilepticus Slc8b1 Cerebral Hemorrhage Stim1 colorectal cancer , common variable immunodeficiency 10 , congenital structural myopathy , Desbuquois dysplasia , esophagus squamous cell carcinoma , Experimental Neoplasms , gastrointestinal stromal tumor , genetic disease , hepatocellular carcinoma , hypertension , immunodeficiency 10 , juvenile rheumatoid arthritis , lung cancer , Lung Neoplasms , lung non-small cell carcinoma , migraine , Neointima , Neoplasm Metastasis , nephrogenic diabetes insipidus , stomach cancer , Stormorken syndrome , Tubular Aggregate Myopathies , tubular aggregate myopathy 1 , Vacuolar Myopathy Stim2 Weight Gain Tpcn1 oligospermia Tpcn2 brain infarction , Marfanoid Mental Retardation Syndrome, Autosomal , Skin/Hair/Eye Pigmentation, Variation In, 10 Trpv5 gestational diabetes , pre-eclampsia Trpv6 Desbuquois dysplasia , genetic disease , gestational diabetes , hyperparathyroidism , polycystic ovary syndrome , pre-eclampsia , Transient Neonatal Hyperparathyroidism
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome Atp2b2 abdominal obesity-metabolic syndrome 1 Atp2a2 achromatopsia Cnga3 , Cngb3 Achromatopsia 1 Cnga3 , Cngb3 achromatopsia 2 Cnga3 achromatopsia 3 Cnga3 , Cngb3 acrodermatitis Itpr3 acrokeratosis verruciformis Atp2a2 Acute Experimental Pancreatitis Atp2a2 acute kidney failure Mcoln1 acute stress disorder Cacna1c adenoid cystic carcinoma Slc24a3 adenoma Atp2a3 , Atp2b3 , Cacna1d adrenal cortical adenoma Atp2b3 agenesis of the corpus callosum with peripheral neuropathy Atp2b2 Aland Island eye disease Cacna1f alcohol dependence Cacna1c Alcohol Myopathy Atp2a1 Alcohol Withdrawal Seizures Cacna1d Alternating Hemiplegia of Childhood 1 Cacna1a Alzheimer's disease Cacna1c , Itpr1 , Slc8a1 , Slc8a2 , Slc8a3 amelogenesis imperfecta Slc24a4 amelogenesis imperfecta hypomaturation type 2A5 Slc24a4 amyloidosis Cacna1c amyotrophic lateral sclerosis Cacna1a , Itpr2 Animal Disease Models Cacna1d , Itpr3 anterior segment dysgenesis Itpr1 , Ryr1 anterior segment dysgenesis 7 Ryr1 anxiety disorder Cacna1c arrhythmogenic right ventricular cardiomyopathy Cacnb2 , Ryr2 arrhythmogenic right ventricular dysplasia 1 Ryr2 arrhythmogenic right ventricular dysplasia 9 Ryr2 arteriovenous malformations of the brain Cacna1h arthrogryposis multiplex congenita Ryr1 asthma Itpr1 Ataxia Cacna1a , Cacnb4 , Itpr1 Auditory Neuropathy Cacna1a autism spectrum disorder Cacna1a , Cacna1c , Cacna1d , Cacnb2 , Itpr3 , Ryr2 autistic disorder Atp2b1 , Cacna1c , Cacna1h , Itpr3 autosomal dominant centronuclear myopathy Ryr1 autosomal dominant cerebellar ataxia Itpr1 autosomal dominant intellectual developmental disorder 26 Ryr1 autosomal dominant intellectual developmental disorder 30 Atp2b1 autosomal dominant intellectual developmental disorder 66 Atp2b1 autosomal dominant nonsyndromic deafness Atp2b2 autosomal dominant nonsyndromic deafness 82 Atp2b2 autosomal recessive Alport syndrome Cacna1d autosomal recessive nonsyndromic deafness 12 Atp2b2 Axial Myopathy, Late-Onset Ryr1 beta thalassemia Cacna1h bipolar disorder Cacna1c , Cacna1d Bradycardia Cacna1d brain disease Cacna1g brain edema Cacna1b Brain Hypoxia Itpr1 , Itpr2 brain infarction Atp2b2 , Tpcn2 brain ischemia Slc8a1 , Slc8a2 , Slc8a3 breast ductal carcinoma Cacna1h Brody myopathy Atp2a1 Brugada syndrome Cacna1c , Cacnb2 , Ryr2 Brugada syndrome 3 Cacna1c Brugada syndrome 4 Cacnb2 Cachexia Atp2a1 , Atp2a2 cardiac arrest Cacnb2 , Itpr1 , Ryr2 Cardiac Arrhythmias Cacna1c , Cacnb2 , Ryr2 Cardiac Conduction Defect Ryr2 Cardiomegaly Atp2a2 , Itpr2 , Slc8a1 cardiomyopathy Cacna1c , Cacnb2 , Ryr1 , Ryr2 cataract Atp2b1 , Cacna1s catecholaminergic polymorphic ventricular tachycardia Ryr2 catecholaminergic polymorphic ventricular tachycardia 1 Ryr2 catecholaminergic polymorphic ventricular tachycardia 2 Ryr2 caudal regression syndrome Ryr1 centronuclear myopathy Cacna1s , Ryr1 centronuclear myopathy 1 Ryr1 cerebellar ataxia Cacna1a , Cacna1g , Itpr1 cerebellar ataxia type 42 Cacna1g Cerebral Hemorrhage Slc24a1 , Slc8b1 cerebral palsy Cacna1a , Cacna1c Charcot-Marie-Tooth Disease Type 1J Itpr3 Chemical and Drug Induced Liver Injury Itpr1 childhood absence epilepsy Cacna1a , Cacna1h Childhood Absence Epilepsy 6 Cacna1h childhood electroclinical syndrome Cacna1a Childhood Schizophrenia Ryr2 clubfoot Atp2b1 , Ryr1 Cognitive Dysfunction Cacna1c colon adenocarcinoma Cacna1d colon adenoma Cacna1d color blindness Cnga3 , Cngb3 colorectal cancer Ryr3 , Stim1 Coma Cacna1e common variable immunodeficiency 10 Stim1 cone dystrophy Cnga3 cone-rod dystrophy Cacna1f , Cnga3 , Cngb3 congenital disorder of glycosylation Iw Cacna1d congenital heart disease Ryr2 Congenital Hip Dislocation Ryr1 Congenital Limb Deformities Cacna1c congenital muscular dystrophy Ryr1 congenital myasthenic syndrome Ryr1 congenital myasthenic syndrome 12 Ryr1 Congenital Mydriasis Itpr1 congenital myopathy Cacna1s , Ryr1 congenital myopathy 18 Cacna1s congenital myopathy 1A Ryr1 congenital myopathy 1B Ryr1 congenital myopathy 20 Ryr3 congenital myopathy 4A Ryr1 Congenital Neuromuscular Disease, with Uniform Type 1 Fiber Ryr1 congenital stationary night blindness Cacna1f , Slc24a1 congenital stationary night blindness 1D Slc24a1 congenital stationary night blindness 2A Cacna1f congenital stationary night blindness autosomal dominant 2 Slc24a1 congenital structural myopathy Orai1 , Ryr1 , Stim1 congestive heart failure Atp2a1 , Atp2a2 , Cacna1c , Ryr1 , Ryr2 , Slc8a1 Contracture Ryr3 Corneal Opacity Mcoln1 coronary artery disease Atp2b1 , Ryr2 Darier Disease, Acral Hemorrhagic Type Atp2a2 Darier Disease, Segmental Atp2a2 Deafness Cacna1d Desbuquois dysplasia Stim1 , Trpv6 developmental and epileptic encephalopathy Cacna1e , Ryr3 developmental and epileptic encephalopathy 1 Cacna1a developmental and epileptic encephalopathy 2 Cacna1a developmental and epileptic encephalopathy 42 Cacna1a developmental and epileptic encephalopathy 52 Cacna1a developmental and epileptic encephalopathy 69 Cacna1e Developmental Disabilities Atp2b3 , Cacna1a , Cacna1i Developmental Disease Cacna1g diabetes mellitus Itpr1 Diabetic Cardiomyopathies Atp2a2 , Ryr2 , Slc8a1 Diabetic Nephropathies Cacna1b Diastolic Dysfunction Ryr2 dilated cardiomyopathy Cacna1c , Cacnb2 , Cacnb4 , Itpr1 , Ryr2 , Slc8a1 dilated cardiomyopathy 1B Ryr2 dilated cardiomyopathy 1C Ryr2 Dilated Cardiomyopathy with Left Ventricular Noncompaction Ryr2 disorder of sexual development Cacna1a distal arthrogryposis Ryr1 Drug-Induced Dyskinesia Cacna1d Drug-Related Side Effects and Adverse Reactions Cacna1h Dwarfism Ryr1 Dysarthria Cacna1a dystonia Atp2b4 dystonia 23 Cacna1b epilepsy Cacna1a , Cacna1c , Cacna1d , Cacnb4 , Itpr1 episodic ataxia Cacna1a , Cacnb4 episodic ataxia type 2 Cacna1a episodic ataxia type 5 Cacnb4 esophagus squamous cell carcinoma Stim1 essential hypertension Atp2a2 euthyroid sick syndrome Atp2a2 exfoliation syndrome Cacna1a Experimental Autoimmune Encephalomyelitis Cacna1b Experimental Diabetes Mellitus Atp2a1 , Atp2a2 , Atp2a3 , Ryr2 , Slc8a1 Experimental Neoplasms Stim1 Eye Abnormalities Cacna1f , Cnga3 , Cngb3 familial hemiplegic migraine Cacna1a familial hemiplegic migraine 1 Cacna1a Familial Hyperaldosteronism, Type IV Cacna1h familial hypertrophic cardiomyopathy Ryr2 Familial Sudden Death Ryr2 Familial Ventricular Tachycardia Ryr2 fetal akinesia deformation sequence syndrome 1 Atp2b3 , Ryr1 Fetal Growth Retardation Cacna1c , Cacna1d focal epilepsy Cacna1h fundus dystrophy Cacna1f , Cnga3 , Cngb1 , Cngb3 , Mcoln1 , Slc24a1 gastrointestinal stromal tumor Stim1 generalized dystonia Cacna1a generalized epilepsy Atp2b2 , Cacna1a , Cacna1h , Cacnb4 , Ryr3 genetic disease Atp2a1 , Atp2a2 , Atp2b1 , Atp2b3 , Atp2c1 , Cacna1a , Cacna1c , Cacna1d , Cacna1e , Cacna1f , Cacna1g , Cacna1h , Cacna1s , Cnga3 , Cngb1 , Cngb3 , Itpr1 , Mcoln1 , Orai1 , Ryr1 , Ryr3 , Slc24a1 , Slc24a4 , Slc24a5 , Stim1 , Trpv6 Genetic Predisposition to Disease Cacna1c gestational diabetes Atp2b1 , Atp2b2 , Atp2b3 , Atp2b4 , Itpr1 , Itpr2 , Itpr3 , Ryr1 , Ryr2 , Ryr3 , Trpv5 , Trpv6 Gillespie syndrome Itpr1 glycoproteinosis Mcoln1 GNE myopathy Ryr1 Growth Disorders Mcoln1 Hailey-Hailey disease Atp2c1 Hearing Loss Atp2b2 , Cacna1d Heart Block Cacna1c , Cacna1d , Ryr2 heart conduction disease Cacnb2 heart disease Atp2a2 , Ryr2 Heat Stroke Ryr1 hepatocellular carcinoma Ryr3 , Stim1 hereditary breast ovarian cancer syndrome Cacna1g hereditary neuropathy with liability to pressure palsies Cacna1s hereditary nonpolyposis colorectal cancer type 5 Ryr1 hereditary spastic paraplegia Mcoln1 hereditary spastic paraplegia 5A Mcoln1 heroin dependence Atp2b1 Huntington's disease Itpr1 hydrocephalus Cacna1i Hydrops Fetalis Ryr1 , Ryr3 Hyperalgesia Cacna1b , Cacna1h , Cacna1i , Itpr1 hyperglycemia Cacna1e hyperparathyroidism Trpv6 hypertension Atp2a3 , Atp2b1 , Atp2b3 , Cacna1c , Cacnb2 , Orai1 , Slc8a1 , Stim1 hypertrophic cardiomyopathy Cacna1c , Cacnb2 , Ryr2 hypertrophic cardiomyopathy 1 Cacna1c , Ryr2 hypertrophic cardiomyopathy 4 Ryr2 hypoglycemia Cacna1c hypokalemic periodic paralysis Cacna1s Hypokalemic Periodic Paralysis, Type 1 Cacna1s hypothyroidism Atp2a2 Hypoxia Itpr1 Idiopathic Generalized Epilepsy Cacna1h , Cacnb4 Idiopathic Generalized Epilepsy 9 Cacnb4 immunodeficiency 10 Stim1 immunodeficiency 133 Itpr3 immunodeficiency 9 Orai1 Infant Death Ryr2 intellectual disability Cacna1a , Cacna1c , Cacna1d , Cacna1e , Cacna1g , Itpr1 , Itpr2 , Mcoln1 intracranial vasospasm Ryr1 invasive ductal carcinoma Cacna1h Iron Overload Atp2a2 isolated anhidrosis with normal sweat glands Itpr2 isolated elevated serum creatine phosphokinase levels Ryr1 Joint Instability Cacna1c juvenile myoclonic epilepsy Cacna1g , Cacnb4 juvenile rheumatoid arthritis Stim1 keratosis follicularis Atp2a2 King Denborough syndrome Ryr1 Lambert-Eaton myasthenic syndrome Cacna1a , Cacna1b Language Development Disorders Cacna1c Lead Poisoning Ryr1 Leber congenital amaurosis Cngb3 left ventricular failure Atp2a2 Left Ventricular Hypertrophy Cacna1g , Ryr1 left ventricular noncompaction Ryr2 Lisch epithelial corneal dystrophy Mcoln1 long QT syndrome Cacna1c , Cacna1d , Cacna1i , Cacna1s , Cacnb2 , Itpr3 , Ryr1 , Ryr2 long QT syndrome 1 Cacna1c , Ryr2 long QT syndrome 8 Cacna1c lung cancer Stim1 Lung Neoplasms Stim1 lung non-small cell carcinoma Stim1 macular degeneration Cacna1f , Cnga3 , Cngb3 major depressive disorder Cacna1c Malignant Fever Cacna1s , Ryr1 malignant hyperthermia Cacna1s , Ryr1 Malignant Hypothermia Ryr1 malignant mesothelioma Ryr2 Marfanoid Mental Retardation Syndrome, Autosomal Tpcn2 megacolon Slc8a1 Memory Disorders Cacna1d Meniere's disease Cacna1d microcephalic osteodysplastic primordial dwarfism type I Ryr2 Microcephalic Osteodysplastic Primordial Dwarfism, Type III Ryr2 migraine Cacna1a , Stim1 migraine with aura Cacna1a Mitochondrial Progressive Myopathy with Congenital Cataract, Hearing Loss, and Developmental Delay Ryr1 Monomelic Amyotrophy Ryr3 movement disease Itpr1 mucolipidosis Mcoln1 mucolipidosis type IV Mcoln1 multiple sclerosis Cacna1b , Itpr1 Muscle Hypotonia Atp2b3 , Ryr1 muscle tissue disease Ryr1 muscular atrophy Cacna1s Myalgia Ryr1 myocardial infarction Ryr1 Myocardial Ischemia Ryr2 , Slc8a1 Myocardial Reperfusion Injury Atp2a1 , Atp2a2 , Slc8a1 myocardial stunning Atp2a2 myoclonic-atonic epilepsy Cacna1a myopathy Ryr1 myopia Cacna1f Myotonia Ryr1 Neointima Atp2a2 , Stim1 Neoplasm Metastasis Orai1 , Stim1 nephrogenic diabetes insipidus Stim1 nephrotoxicity Cacna1g , Cacna1s , Itpr1 , Ryr1 Nerve Injuries Cacnb2 , Cacnb3 Nervous System Malformations Cacna1a , Mcoln1 neurodegenerative disease Itpr1 neurodevelopmental disorder with dysmorphic facies and distal limb anomalies Cacna1c neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures Cacna1a , Cacna1c Neurodevelopmental Disorder with Seizures and Nonepileptic Hyperkinetic Movements Cacna1b Neurodevelopmental Disorder with Speech Impairment and with or without Seizures Cacna1i Neurodevelopmental Disorders Atp2b1 , Atp2b2 , Atp2b3 , Cacna1a , Cacna1b , Cacna1c , Cacna1g , Itpr1 neuromuscular disease Ryr1 Niemann-Pick disease type A Itpr1 ocular albinism 1 Slc24a5 oculocutaneous albinism type VI Slc24a5 oligospermia Tpcn1 optic atrophy Cacna1f , Cnga3 , Cngb1 , Cngb3 osteochondrodysplasia Ryr1 osteogenesis imperfecta type 1 Ryr1 osteoporosis Ryr1 ovarian cyst Cacnb3 Paroxysmal Ventricular Fibrillation Cacnb2 , Ryr2 pathologic nystagmus Cngb3 peripheral nervous system disease Cacna1b , Cacna1h periventricular leukomalacia Mcoln1 polycystic ovary syndrome Trpv6 post-traumatic stress disorder Cacna1c pre-eclampsia Atp2b1 , Atp2b2 , Atp2b3 , Atp2b4 , Itpr1 , Itpr2 , Itpr3 , Ryr1 , Ryr2 , Ryr3 , Trpv5 , Trpv6 Presbycusis Cacna1d Primary Aldosteronism, Seizures, and Neurologic Abnormalities Cacna1d primary hyperaldosteronism Atp2b3 , Cacna1d , Cacna1h primary immunodeficiency disease Cacna1c primary ovarian insufficiency Ryr3 primary pulmonary hypertension Ryr1 progressive bulbar palsy Cacna1a prostate cancer Atp2b4 , Cacna1d , Slc8a3 Prostatic Neoplasms Itpr1 Psychomotor Agitation Cacna1c ptosis Ryr1 pulmonary hypertension Atp2a2 , Ryr1 , Ryr2 , Ryr3 , Slc8a1 renal cell carcinoma Ryr1 Reperfusion Injury Slc8a1 , Slc8a2 , Slc8a3 respiratory failure Cacna1s , Ryr1 retinitis pigmentosa Cacna1f , Cnga1 , Cngb1 , Cngb3 , Slc24a1 retinitis pigmentosa 1 Cacna1f , Cnga1 , Cnga3 , Cngb1 , Cngb3 , Slc24a1 retinitis pigmentosa 45 Cngb1 retinitis pigmentosa 49 Cnga1 , Cngb1 Rhabdomyolysis Cacna1s , Ryr1 Rhabdomyolysis 2 Atp2a2 rigid spine muscular dystrophy 1 Ryr1 Romano-Ward Syndrome Cacna1c Salivary Gland Neoplasms Slc24a3 schizophrenia Cacna1i sciatic neuropathy Cacna1d , Cacna1h , Cacna1i scoliosis Ryr1 Sepsis Atp2a1 , Cacna1s , Ryr1 short QT syndrome Cacna1c , Cacnb2 sick sinus syndrome Cacna1d Sinoatrial Node Dysfunction and Deafness Cacna1d Skin/Hair/Eye Pigmentation, Variation In, 10 Tpcn2 Skin/Hair/Eye Pigmentation, Variation In, 4 Slc24a5 Skin/Hair/Eye Pigmentation, Variation In, 6 Slc24a4 spastic ataxia Atp2b3 , Cacna1a , Cacna1g , Cacnb4 , Itpr1 Spastic Paraparesis Cacna1a Spinal Cord Injuries Atp2a1 , Atp2a2 , Ryr1 spinocerebellar ataxia 15 Itpr1 spinocerebellar ataxia 29 Itpr1 Spinocerebellar Ataxia 42, Early-Onset, Severe, with Neurodevelopmental Deficits Cacna1g spinocerebellar ataxia 6 Cacna1a Spinocerebellar Ataxias Cacna1a , Cacna1g , Itpr1 Sporadic Hemiplegic Migraine Cacna1a Stargardt disease Cngb3 Stargardt Disease 1 Cngb3 status epilepticus Atp2a2 , Slc8a1 , Slc8a2 , Slc8a3 stomach cancer Stim1 Stormorken syndrome Orai1 , Stim1 subependymal giant cell astrocytoma Cacna1a Sudden Cardiac Death Cacna1c , Ryr2 Sudden Death Cacna1c , Cacnb2 , Ryr2 sudden infant death syndrome Cacna1a Sudden Unexpected Nocturnal Death Syndrome Cacna1c , Cacnb2 Supraventricular Tachycardia Cacna1d , Cacnb2 Syncope Ryr2 Tachycardia Ryr2 temporal lobe epilepsy Cacna1a tetralogy of Fallot Cacna1c Thyrotoxic Periodic Paralysis Cacna1s Timothy syndrome Cacna1c transient cerebral ischemia Itpr1 Transient Neonatal Hyperparathyroidism Trpv6 Tremor Atp2b3 , Cacna1a , Cacna1c Tubular Aggregate Myopathies Orai1 , Stim1 tubular aggregate myopathy 1 Orai1 , Ryr1 , Stim1 tubular aggregate myopathy 2 Orai1 type 1 diabetes mellitus Itpr3 type 2 diabetes mellitus Atp2a1 , Atp2a2 , Atp2a3 , Cacna1d Uncombable Hair Syndrome 1 Ryr1 Vacuolar Myopathy Stim1 Van der Woude Syndrome 1 Cacna1e vascular dementia Cacna1a Ventricular Fibrillation Cacnb2 , Ryr2 Ventricular Fibrillation, Paroxysmal Familial, 1 Cacna1c , Ryr2 Ventricular Tachycardia Atp2a2 , Cacna1c , Cacnb2 , Ryr2 Ventriculomegaly Cacna1i Weight Gain Stim2 withdrawal disorder Cacna1i Wolff-Parkinson-White syndrome Cacna1c , Cacna1e , Ryr2 X-linked cone-rod dystrophy 3 Cacna1f X-linked spinocerebellar ataxia 1 Atp2b3